May 23, 2022 4:10pm EDT Ensysce Biosciences Announces Initiation of First Human Abuse Potential Study
May 12, 2022 4:10pm EDT Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results
May 05, 2022 9:15am EDT Ensysce Biosciences Announces New Clinical Results from Trials PF614-102 and PF614-MPAR-101
Apr 20, 2022 4:05pm EDT Dr. Lynn Kirkpatrick, Invited Speaker at SMi 22nd Annual Pain Therapeutics Conference in London UK
Apr 18, 2022 4:05pm EDT Ensysce Biosciences Announces Appointment of Dr. Nily Osman as Chief Medical Officer
Mar 31, 2022 4:05pm EDT Ensysce Biosciences Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 24, 2022 5:10pm EDT Ensysce Biosciences Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Timing of Corporate Update Call
Feb 23, 2022 8:31am EST Ensysce Biosciences Announces Participation in the 34th Annual Roth Conference
Feb 08, 2022 4:01pm EST Ensysce Biosciences Appoints Industry Veteran Lee Rauch to Board of Directors
